VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial
Previous
Previous
Press Release: Health Wildcatters’ 2024 edition of Texas Healthcare Challenge Integrates AI Features to Accelerate Healthcare Innovation in Annual Hackathon
Next
Next